Landry Robert E — SEC insider filings

SEC reporting owner CIK 1585160. 36 insider filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-12-11 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REGENERON PHARMACEUTICALS, INC. (REGN)EVP Finance CFO29—118 legs · 12,702 sh · $9,147,867120
CYTOKINETICS INC (CYTK)Director5—2 legs · 2,000 sh · $146,7905
Zymeworks Inc. (ZYME)Director2——3

Insider filings — Landry Robert E

FiledFormIssuerReported transactionsSource
2026-09-154CYTOKINETICS INC (CYTK)Sale (S): 1,000 @ $72.13EDGAR
2026-09-114CYTOKINETICS INC (CYTK)Sale (S): 1,000 @ $74.66EDGAR
2026-05-274CYTOKINETICS INC (CYTK)Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0EDGAR
2026-01-124Zymeworks Inc. (ZYME)Grant/award (A): 11,500 (derivative) @ $0 · Grant/award (A): 7,700 (derivative) @ $0EDGAR
2025-08-124Zymeworks Inc. (ZYME)Grant/award (A): 62,000 (derivative) @ $0EDGAR
2025-05-144CYTOKINETICS INC (CYTK)Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0EDGAR
2025-02-114CYTOKINETICS INC (CYTK)Grant/award (A): 25,538 (derivative) @ $0EDGAR
2024-02-064REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 400 @ $378.98 · Tax withholding (F): 281 @ $956.65 · Option exercise (M): 400 (derivative) @ $0EDGAR
2024-02-024REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 400 @ $378.98 · Tax withholding (F): 282 @ $953.42 · Option exercise (M): 400 (derivative) @ $0EDGAR
2024-01-254REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,100 @ $378.98 · Tax withholding (F): 776 @ $948.50 · Option exercise (M): 500 @ $378.98 · Tax withholding (F): 352 @ $951.26 · Option exercise (M): 1,100 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0EDGAR
2024-01-184REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 500 @ $378.98 · Tax withholding (F): 354 @ $932.34 · Option exercise (M): 500 (derivative) @ $0EDGAR
2024-01-174REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 800 @ $378.98 · Tax withholding (F): 568 @ $928.18 · Option exercise (M): 800 (derivative) @ $0EDGAR
2024-01-084REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 500 @ $378.98 · Tax withholding (F): 342 @ $917.05 · Option exercise (M): 500 (derivative) @ $0EDGAR
2024-01-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 650 @ $378.98 · Tax withholding (F): 421 @ $888.34 · Option exercise (M): 1,100 @ $378.98 · Tax withholding (F): 688 @ $912.30 · Option exercise (M): 650 (derivative) @ $0 · Option exercise (M): 1,100 (derivative) @ $0EDGAR
2023-12-294REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 750 @ $378.98 · Tax withholding (F): 542 @ $872.21 · Option exercise (M): 850 @ $378.98 · Tax withholding (F): 612 @ $884.88 · Option exercise (M): 750 (derivative) @ $0 · Option exercise (M): 850 (derivative) @ $0EDGAR
2023-12-144REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 6,381 @ $856.71 · Option exercise (M): 1,000 @ $378.98 · Tax withholding (F): 723 @ $871.12 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2023-12-124REGENERON PHARMACEUTICALS, INC. (REGN)Tax withholding (F): 1,013 @ $843.79 · Tax withholding (F): 669 @ $844.09 · Tax withholding (F): 2,552 @ $844.09EDGAR
2023-08-254REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 223 @ $844EDGAR
2023-03-294REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 800 @ $381.92 · Tax withholding (F): 589 @ $825.17 · Option exercise (M): 3,000 @ $378.98 · Tax withholding (F): 2,204 @ $825.17 · Sale (S): 39 @ $819.47 · Sale (S): 50 @ $820.46 · +16 moreEDGAR
2023-02-074REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 739 @ $764.50 · Option exercise (M): 3,000 @ $381.92 · Tax withholding (F): 2,248 @ $774.29 · Sale (S): 51 @ $783.05 · Sale (S): 113 @ $784.27 · Sale (S): 78 @ $785.88 · +12 moreEDGAR
2022-12-204REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 3,853 @ $0 · Grant/award (A): 14,222 (derivative) @ $0EDGAR
2022-12-124REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 3,000 @ $381.92 · Tax withholding (F): 2,261 @ $768.54 · Tax withholding (F): 492 @ $753.28 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2022-12-024REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2,500 @ $381.92 · Tax withholding (F): 1,890 @ $760.35 · Sale (S): 582 @ $756.50 · Sale (S): 16 @ $759.90 · Sale (S): 12 @ $760.19 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2022-11-024REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2,000 @ $381.92 · Tax withholding (F): 1,518 @ $751.24 · Sale (S): 1 @ $750 · Sale (S): 40 @ $753.23 · Sale (S): 80 @ $754.39 · Sale (S): 81 @ $755.46 · +7 moreEDGAR
2022-10-184REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,500 @ $381.92 · Tax withholding (F): 1,142 @ $743.78 · Sale (S): 358 @ $739.50 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2022-04-114REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,500 @ $399.66 · Tax withholding (F): 1,175 @ $716.09 · Sale (S): 16 @ $724.33 · Sale (S): 30 @ $728.77 · Sale (S): 16 @ $729.67 · Sale (S): 44 @ $733.38 · +22 moreEDGAR
2022-04-014REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,500 @ $399.66 · Tax withholding (F): 1,184 @ $700.99 · Sale (S): 301 @ $695.50 · Sale (S): 15 @ $701.98 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2022-03-304REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,250 @ $555.67 · Tax withholding (F): 1,134 @ $685.26 · Option exercise (M): 1,250 @ $555.67 · Tax withholding (F): 1,134 @ $685.26 · Option exercise (M): 4,000 @ $399.66 · Tax withholding (F): 3,183 @ $685.26 · +23 moreEDGAR
2022-03-234REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 300 @ $693 · Option exercise (M): 400 @ $381.92 · Tax withholding (F): 312 @ $691.31 · Option exercise (M): 400 (derivative) @ $0EDGAR
2022-03-184REGENERON PHARMACEUTICALS, INC. (REGN)Sale (S): 300 @ $677 · Sale (S): 83 @ $686 · Option exercise (M): 365 @ $381.92 · Tax withholding (F): 286 @ $682.50 · Option exercise (M): 365 (derivative) @ $0EDGAR
2021-12-144REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,500 @ $555.67 · Tax withholding (F): 1,384 @ $664.34 · Tax withholding (F): 697 @ $664.34 · Sale (S): 116 @ $662.50 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2021-12-104REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 3,971 @ $0 · Option exercise (M): 4,250 @ $399.66 · Tax withholding (F): 3,469 @ $657.11 · Sale (S): 2 @ $656.46 · Sale (S): 50 @ $657.53 · Sale (S): 11 @ $658.52 · +15 moreEDGAR
2021-11-184REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 3,750 @ $399.66 · Tax withholding (F): 3,069 @ $651.97 · Sale (S): 681 @ $645.08 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2021-09-014REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,000 @ $555.67 · Tax withholding (F): 917 @ $675.03 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2021-08-104REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 2,000 @ $381.92 · Tax withholding (F): 1,636 @ $607.51 · Sale (S): 1 @ $610.85 · Sale (S): 36 @ $612.97 · Sale (S): 1 @ $613.79 · Sale (S): 66 @ $614.70 · +16 moreEDGAR
2020-12-114REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 1,930 @ $0 · Grant/award (A): 19,950 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs